The city of Tucson, Arizona, currently has 4 active clinical trials seeking participants for Alzheimer's Disease research studies.
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
NCT06653153
Recruiting
The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in participants receiving study drug compared to placebo. Participation could last up to 255 weeks including screening, a double-blind treatment period, and a double-blind observation period. In addition, eligible participants who receive placebo during the double-blind treatment period may choose to extend their study participat... Read More
Gender:
ALL
Ages:
Between 55 years and 80 years
Trial Updated:
07/30/2025
Locations: Banner Alzheimer's Institute Tucson, Tucson, Arizona
Conditions: Alzheimer's Disease
Register for Updates
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
NCT05026866
Recruiting
The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD). Approximately 800 additional participants will be enrolled in a 12-month addendum to assess safety of a different titration regimen.
Gender:
ALL
Ages:
Between 65 years and 80 years
Trial Updated:
06/24/2025
Locations: Banner Alzheimer's Institute Tucson, Tucson, Arizona +1 locations
Conditions: Alzheimer Disease
Register for Updates
Arizona Alzheimer's Disease Research Center (ADRC)
NCT05405075
Recruiting
The Arizona Alzheimer's Disease Research Center (ADRC) is the National Institute on Aging's (NIA's) first statewide AD Center (ADC), the only ADC in the Southwestern United States, and a leading example of statewide collaboration in biomedical research. It capitalizes on Arizona's strengths in brain imaging, genomics, computer science and biomathematics, the basic, cognitive and behavioral neurosciences, clinical, and neuropathological studies of AD, the discovery and evaluation of investigation... Read More
Gender:
ALL
Ages:
40 years and above
Trial Updated:
08/16/2024
Locations: Banner Alzheimer's Institute - Tucson, Tucson, Arizona
Conditions: Alzheimer Disease
Register for Updates
Alzheimer's Disease Core Center
NCT01421420
Recruiting
The main objective of this research project is to provide a comprehensive clinical database of patients with Alzheimer's disease (AD) and other forms of dementia, individuals with mild cognitive impairment (MCI), and age-matched normal controls. The study will also attempt to identify cognitively normal individuals at genetically defined risk for Alzheimer's disease through genetic screening. All participants are seen annually. Autopsies to establish diagnoses in patients with dementia, patient... Read More
Gender:
ALL
Ages:
50 years and above
Trial Updated:
06/10/2015
Locations: University of Arizona, University Medical Center, Tucson, Arizona
Conditions: Alzheimer's Disease, Mild Cognitive Impairment, Age-Related Memory Disorders
Register for Updates